Visceral leishmaniasis (VL) is a deadly, vector-borne, neglected tropical disease endemic to arid parts of the world and is caused by a protozoan parasite of the genus . Chemotherapy is the primary treatment for this systemic disease, and multiple potent therapies exist against this intracellular parasite. However, several factors, such as systemic toxicity, high costs, arduous treatment regimen, and rising drug resistance, are barriers for effective therapy against VL. Material-based platforms have the potential to revolutionize chemotherapy for leishmaniasis by imparting a better pharmacokinetic profile and creating patient-friendly routes of administration, while also lowering the risk for drug resistance. This review highlights promising drug delivery strategies and novel therapies that have been evaluated in preclinical models, demonstrating the potential to advance chemotherapy for VL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372633 | PMC |
| http://dx.doi.org/10.1021/acsbiomaterials.0c01132 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unsupervised machine learning identifies biomarkers of disease progression in post-kala-azar dermal leishmaniasis in Sudan.
PLoS Negl Trop Dis
March 2025
WHO Collaborating Centre for Leishmaniasis. Spanish National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain.
Background: Post-kala-azar dermal leishmaniasis (PKDL) appears as a rash in some individuals who have recovered from visceral leishmaniasis caused by Leishmania donovani. Today, basic knowledge of this neglected disease and how to predict its progression remain largely unknown.
Methods And Findings: This study addresses the use of several biochemical, haematological and immunological variables, independently or through unsupervised machine learning (ML), to predict PKDL progression risk.
Leishmaniasis in deployed military populations: A systematic review and meta-analysis.
PLoS Negl Trop Dis
March 2025
School of Life Sciences, University of Warwick, Warwick, United Kingdom.
Leishmaniasis affects military personnel deployed to endemic areas following exposure to sand flies infected with the protozoa Leishmania. This systematic review and meta-analysis of data specific to military populations aims to identify knowledge gaps to mitigate sand fly exposure and Leishmania transmission during deployments. The review was registered on PROSPERO (CRD42023463687).
View Article and Find Full Text PDFPrevalent zoonoses in Sao Paulo State, Brazil: the role of bats and molecular diagnosis.
Rev Inst Med Trop Sao Paulo
March 2025
Universidade Estadual Paulista, Departamento de Produção Animal e Medicina Veterinária Preventiva, Botucatu, São Paulo, Brazil.
This review explores the landscape of prevalent zoonotic diseases in Sao Paulo State, Brazil, focusing on the role of bats as reservoirs and the application of molecular biology in the diagnosis. The zoonoses covered include visceral and cutaneous leishmaniasis, Chagas disease, toxoplasmosis, bartonellosis, Q fever, Brazilian spotted fever, and leptospirosis. Molecular techniques can improve public health responses by accurately identifying pathogens and tracking their transmission dynamics in populations, thus enhancing early detection, characterization of strains, and monitoring of disease outbreaks.
View Article and Find Full Text PDFLeishmaniases: Strategies in treatment development.
Parasite
March 2025
Université Côte d'Azur, INSERM U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), BP 23194, 06204 Nice Cedex 3, France - Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Nice, Hôpital de l'Archet, CS 23079, 06202 Nice Cedex 3, France.
Leishmaniases are vector-borne parasitic diseases that pose a threat to over 1 billion people worldwide. The parasites target cells of the reticulohistiocytic system, such as macrophages, where they replicate. The disease manifests in various forms, ranging from localized cutaneous leishmaniasis to life-threatening visceral forms, which are fatal in 95% of cases without treatment.
View Article and Find Full Text PDFKala-azar elimination in India: reflections on success and sustainability.
Int Health
March 2025
Directorate of National Centre for Disease Control, New Delhi 110054, India.
The incidence and mortality of kala-azar (KA, visceral leishmaniasis) in India have fallen drastically in the past few years, and in 2023 the reported KA incidence reached the threshold for elimination as a public health problem (<1 case/10 000 of population at subdistrict level). One of the strategies adopted by India's kala-azar elimination program (KAEP) was the regular independent assessment of the program implementation by teams of experts. We present the findings of assessments undertaken in 2019, 2021 and 2023, when the KAEP was in the last mile of elimination.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!